Litigation Details for Aralez Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2017)
✉ Email this page to a colleague
Aralez Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-01-23 |
| Court | District Court, E.D. Texas | Date Terminated | 2017-10-30 |
| Cause | 35:271 Patent Infringement | Assigned To | James Rodney Gilstrap |
| Jury Demand | None | Referred To | Roy S. Payne |
| Parties | ARALEZ PHARMACEUTICALS INC. | ||
| Patents | 6,926,907; 8,206,741; 9,364,439; 9,539,214 | ||
| Attorneys | Allan A Kassenoff; Richard Charles Pettus | ||
| Firms | Fitzpatrick Cella Harper & Scinto - New York; Ward, Smith & Hill, PLLC | ||
| Link to Docket | External link to docket | ||
Details for Aralez Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Tex. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-01-22 | 1 | United States Patent Nos. 6,926,907 (“the ’907 patent”), 8,206,741 (“the ’741 patent”), 9,364,439 (“…907 Patent, # 3 Exhibit B - '741 Patent, # 4 Exhibit C - '439 Patent, # 5 Exhibit D - '214 Patent)(Hill…(“the ’439 patent”), and 9,539,214 (“the ’214 patent”) under the Patent Laws of the United States, 35… THE PATENTS-IN-SUIT 19. On August 9, 2005, the ’907 patent, entitled “Pharmaceutical… ’741 patent is attached hereto as Exhibit B. 21. On June 14, 2016, the ’439 patent, entitled | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
